Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael MacLean Insider Profile
4 Followers
Michael MacLean, SVP & CAO at Biogen, holds 94.09K shares in Avidity Biosciences (Ticker: RNA), holds 48.00K shares in Akcea Therapeutics (Ticker: AKCA), holds 10.68K shares in Biogen (Ticker: BIIB).
Michael MacLean has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael MacLean holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael MacLean
Michael MacLean's Trading History
Biogen
Oct 04, 2010
SVP & CAO
Uninformative Sell
53.87K
$1.69M
Akcea Therapeutics
Jan 16, 2020
―
Uninformative Buy
―
$872.16K
Avidity Biosciences
Nov 08, 2024
CFO
Uninformative Buy
666.06K
$4.07M
Verve Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Michael MacLean's performance on stock
You May Also Like
Michael MacLean insider profile FAQ
What is the percentage of profitable transactions made by Michael MacLean?
The percentage of profitable transactions made by Michael MacLean is ―.
What is the average return per transaction made by Michael MacLean?
The average return per transaction made by Michael MacLean is ―.
What stocks does Michael MacLean hold?
Michael MacLean holds: BIIB, AKCA, RNA, VERV stocks.
What was Michael MacLean’s latest transaction?
Michael MacLean latest transaction was an Uninformative Buy of $666.06K.
What was Michael MacLean's most profitable transaction?
Michael MacLean’s most profitable transaction was an Informative Sell of RNA stock on March 15, 2024. The return on the trade was -77.10%.
What is Michael MacLean's role in Biogen?
Michael MacLean's role in Biogen is SVP & CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.